Eversept Partners, LP Astrazeneca PLC Transaction History

Eversept Partners, LP

$1.26 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 08, 2023	BUY	$59.26 - $71.14 $16.3 Million - $19.6 Million	275,066 Added 36.91%	1,020,329 $67.4 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $16.3 Million - $19.6 Million	275,066 Added 36.91%	1,020,329 $67.4 Million
Q1 2022 Nov 08, 2023	BUY	$55.72 - $67.12 $41.5 Million - $50 Million	745,263 New	745,263 $49.4 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $11.4 Million - $13.7 Million	-203,961 Reduced 21.49%	745,263 $49.4 Million
Q4 2021 Nov 08, 2023	BUY	$54.02 - $63.83 $3.16 Million - $3.73 Million	58,416 Added 6.56%	949,224 $55.3 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $3.16 Million - $3.73 Million	58,416 Added 6.56%	949,224 $55.3 Million
Q3 2021 Nov 08, 2023	SELL	$55.56 - $60.79 $5.27 Million - $5.77 Million	-94,914 Reduced 9.63%	890,808 $53.5 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $5.27 Million - $5.77 Million	-94,914 Reduced 9.63%	890,808 $53.5 Million
Q2 2021 Nov 08, 2023	SELL	$48.42 - $60.18 $319,233 - $396,766	-6,593 Reduced 0.66%	985,722 $59 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $319,233 - $396,766	-6,593 Reduced 0.66%	985,722 $59 Million
Q1 2021 Nov 08, 2023	BUY	$47.16 - $54.44 $6.6 Million - $7.62 Million	139,884 Added 16.41%	992,315 $49.3 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $6.6 Million - $7.62 Million	139,884 Added 16.41%	992,315 $49.3 Million
Q4 2020 Nov 08, 2023	BUY	$48.52 - $58.02 $41.4 Million - $49.5 Million	852,431 New	852,431 $42.6 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $38.4 Million - $45.9 Million	791,495 Added 1298.9%	852,431 $42.6 Million
Q3 2020 Nov 08, 2023	SELL	$53.07 - $61.1 $26.6 Million - $30.6 Million	-501,215 Reduced 89.16%	60,936 $3.34 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $26.6 Million - $30.6 Million	-501,215 Reduced 89.16%	60,936 $3.34 Million
Q2 2020 Nov 08, 2023	BUY	$43.1 - $55.31 $9.03 Million - $11.6 Million	209,600 Added 59.45%	562,151 $29.7 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $9.03 Million - $11.6 Million	209,600 Added 59.45%	562,151 $29.7 Million
Q1 2020 Nov 08, 2023	BUY	$37.79 - $51.33 $8.01 Million - $10.9 Million	211,989 Added 150.82%	352,551 $15.7 Million
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $8.01 Million - $10.9 Million	211,989 Added 150.82%	352,551 $15.7 Million
Q4 2019 Nov 08, 2023	BUY	$42.46 - $50.46 $5.97 Million - $7.09 Million	140,562 New	140,562 $7.01 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $5.97 Million - $7.09 Million	140,562 New	140,562 $7.01 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account